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A Branch Point of Streptomyces Sulfur Amino Acid Metabolism
Controls the Production of Albomycin
Aditya Kulkarni,a Yu Zeng,a Wei Zhou,a Steven Van Lanen,b Weiwen Zhang,c Shawn Chena
Department of Biological Sciences, Ohio University, Athens, Ohio, USAa; Department of Pharmaceutical Sciences, University of Kentucky College of Pharmacy, Lexington,
Kentucky, USAb; Laboratory of Synthetic Microbiology, School of Chemical Engineering & Technology, Tianjin University, Tianjin, People’s Republic of Chinac
Albomycin (ABM), also known as grisein, is a sulfur-containing metabolite produced by Streptomyces griseus ATCC 700974.
Genes predicted to be involved in the biosynthesis of ABM and ABM-like molecules are found in the genomes of other actinomy-
cetes. ABM has potent antibacterial activity, and as a result, many attempts have beenmade to develop ABM into a drug since the
last century. Although the productivity of S. griseus can be increased with randommutagenesis methods, understanding of
Streptomyces sulfur amino acid (SAA) metabolism, which supplies a precursor for ABM biosynthesis, could lead to improved
and stable production. We previously characterized the gene cluster (abm) in the genome-sequenced S. griseus strain and pro-
posed that the sulfur atom of ABM is derived from either cysteine (Cys) or homocysteine (Hcy). The gene product, AbmD, ap-
pears to be an important link between primary and secondary sulfur metabolic pathways. Here, we show that propargylglycine
or iron supplementation in growthmedia increased ABM production by significantly changing the relative concentrations of
intracellular Cys and Hcy. An SAAmetabolic network of S. griseuswas constructed. Pathways toward increasing Hcy were
shown to positively impact ABM production. The abmD gene and five genes that increased the Hcy/Cys ratio were assembled
downstream of hrdBp promoter sequences and integrated into the chromosome for overexpression. The ABM titer of one engi-
neered strain, SCAK3, in a chemically definedmediumwas consistently improved to levels400% of the wild type. Finally, we
analyzed the production and growth of SCAK3 in shake flasks for further process development.
The Streptomyces genus was established at the beginning of thegolden age of antibiotic discovery (1). Streptomyces griseus, a
representative organism of the genus (2), was shown during this
time to produce streptomycin (3), which has been clinically used
to treat bacterial infections and other human diseases. It is well
known that Streptomyces organisms in general have a large biosyn-
thetic potential, being capable of producing many bioactive sec-
ondary metabolites—the S. griseus strains producing albomycin
(ABM) are no exception. ABM was named by former Soviet Union
scientists and underwent clinical investigations well before the
information was released to the English-speaking scientific world
(4). The biological activity and chemical constitution of ABM
were later reported to be nearly identical to those of grisein, which
was isolated from a distinct subtype of S. griseus by U.S. scientists
in the 1940s (5–7). Despite its remarkable properties, continued
studies of ABM were not pursued, partly because of the poor yields
(8) and unpublicized research on the microorganism (9, 10). At
present, the wealth of Streptomyces genomic information that is
publically available provides the possibility of using a systems bi-
ology approach to uncover new aspects of Streptomyces metabo-
lism and potentially overcome the production bottleneck.
ABM and ABM-like secondary metabolites are structurally cat-
egorized as peptidyl nucleoside antibiotics (Fig. 1). The N termi-
nus of the peptide is a ferrichrome siderophore moiety in ABM;
thus, many human-pathogenic bacteria (e.g., pneumococci and
enterics) actively take up ABM through an iron transport system
as a mechanism to acquire iron from the environment (11). Once
inside the pathogen, a serine-containing nucleosyl dipeptide,
termed SB-217452 (12), at the C terminus of ABM is enzymati-
cally released through hydrolysis. SB-217452 has been proposed to
mimic seryl-AMP and therefore function as an antibiotic by in-
hibiting seryl-tRNA synthetase (SerRS), an essential enzyme in-
volved in protein synthesis. The nucleoside component of
SB-217452 consists of a highly unusual cyclic thioether group
(OCOSOCO) that, along with several other features, including
the C-3= stereochemical configuration and additional base modi-
fications, differentiates it from the canonical nucleosides. It was
reported that the sulfur atom of ABM cannot be replaced with an
oxygen; a chemically synthesized compound with the oxygen sub-
stitution completely lost biological activity (13). Studies aimed at
defining ABM biosynthesis, such as the assembly of the empow-
ered siderophore and the intriguing mechanism for the formation
of this rare thiosugar-containing amino acid, including the iden-
tity of the precursor metabolite(s) in the ABM-producing S. gri-
seus, could help alleviate the bottlenecks to bringing an ABM-
inspired antibiotic to the clinic.
Bacterial sulfur amino acid (SAA) metabolism is highly adap-
tive and diversified (14). Biosynthesis of cysteine (Cys) and me-
thionine (Met) via homocysteine (Hcy) are linked through
bidirectional transsulfuration pathways. Each transsulfuration
direction involves two sequential reactions that are catalyzed by
different enzymes that often have relaxed specificities (Fig. 1).
Interconversion between Hcy and Met occurs in the activated
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methyl cycle (AMC)—the so-called Met salvage pathway—which
involves ATP and additional cofactors, such as cobalamin (vita-
min B12) or 5-methyl-tetrahydrofolate. The intrinsic function and
metabolic branching of AMC have been shown to lead to the pro-
duction of some bacterial metabolites (e.g., quorum-sensing mol-
ecules, etc.) that can have a profound impact on the bacterial
physiology and surrounding microbial community. SAA metab-
olism is also connected with aspartate metabolism via homoser-
ine. However, most Streptomyces spp. and other actinobacteria do
not encode a MetA enzyme, which acylates the hydroxyl of homo-
serine with succinyl coenzyme A (succinyl-CoA). Instead, a direct
sulfhydrylation pathway comprising metX and metY is found in
some actinomycetes (Fig. 1) (15, 16). Furthermore, Streptomyces
coelicolor apparently lacks not only metA but also metXY (17); this
aspect of Met synthesis in what is often considered the model
Streptomyces organism remains unsolved. Most actinobacterial
genomes also do not appear to have a canonical metC that codes
for a cystathionine--lyase (14); it has been suggested that the
malY gene product may perform this function (18). The geneti-
cally amenable ABM-producing species S. griseus is proposed as an
excellent system for investigation into Streptomyces SAA metabo-
lism and the interplay of primary and specialized metabolism,
since the results may have a direct impact on industrial produc-
tion of the ABM antibiotic.
We initiated research on ABM biosynthesis with one aim: to
improve ABM production in a native producer, S. griseus ATCC
700974 (19–21). A draft genome sequence of S. griseus was ob-
tained, and the ABM biosynthetic gene cluster (abm) was identi-
fied. Based on previous reports (22, 23), the purification and an-
alytical determination of ABM were established, and a robust
genetic system within S. griseus was developed to link the genetic
information with ABM production. In collaboration with others,
we also developed an in vitro enzyme assay for SerRS to show that
SB-217452 cleaved from purified ABM is indeed a potent inhibi-
tor of the enzyme activity. Interestingly, the abm gene cluster lacks
an obvious pathway-specific regulatory gene, suggesting that
ABM production might be controlled by the availability of a sul-
fur-containing primary metabolite. The protein encoded by
abmD was identified as the best candidate to catalyze the first
committed step in the biosynthesis of the nucleoside component
of ABM using one of the known sulfur-containing primary me-
tabolites. Here, we present experimental evidence to support
this hypothesis, obtained by manipulating the newly identified
genes of Streptomyces SAA metabolism, measuring the intracellu-
lar Hcy/Cys ratio, and performing fermentation optimization
studies. The level of ABM production by S. griseus was increased
4-fold, and cell level analysis indicated that Hcy is directly in-
volved in ABM biosynthesis.
FIG 1 Constructed sulfur amino acid metabolism and the linked metabolic network in Streptomyces griseus. Corresponding to the conventional name shown,
the identified S. griseus ORF and its product are as follows: (1) sgr6646, homoserine O-acetyltransferase; (2) sgr6647, O-acetylhomoserine sulfhydrylase; (3)
sgr2579, cystathionine--synthase (CGS); (4) sgr3417, type II cystathionine--lyase (CBL); (5) sgr5847, B12-dependent methionine synthase; (6) sgr1212,
B12-independent methionine synthase; (7) sgr6058, S-adenosylmethionine (SAM) synthetase; (8) sgr4513, S-adenosylhomocysteine (SAH) hydrolase; (9)
sgr4452, cystathionine--synthase (CBS); and (10) sgr3660, cystathionine--lyase (CGL). The abmD gene product is proposed to be a critical link between sulfur
amino acid metabolism and ABM biosynthesis.
Kulkarni et al.
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MATERIALS AND METHODS
Bacterial strains, plasmids, reagents, and growth media. The bacterial
strains and plasmids used are listed in Table 1. Primers for PCR amplifi-
cation are in Table 2. Chemicals were purchased from standard commer-
cial sources. General Streptomyces microbiological procedures were fol-
lowed (24). The original ABM production broth (APB) consisted of the
following (23): 20 g of starch, 5 g of L-ornithine HCl, 1.8 g of KH2PO4, 10.2
g of Na2HPO4, 2 g of (NH4)2SO4, 2 g of NaCl, 2 g of MgSO4·7H2O, 0.8 g
of CaCl2·2H2O, 0.28 g of FeSO4·7H2O, and 0.02 g of ZnSO4·7H2O per liter
of distilled water. To simplify ABM purification here, APB was modified
to contain 20 g of glycerol as the sole carbon source, and ornithine and
starch were omitted. Streptomyces spores and mycelia were routinely
maintained on mannitol-soya flour (MS) agar plates. Streptomyces seed
culture was in tryptic soy broth (TSB). Escherichia coli strains were cul-
tured in Luria-Bertani (LB) broth or agar.
Standard DNAmanipulation and Streptomyces genetic techniques.
Plasmids and DNA fragments were purified according to the provided
protocol (Qiagen). Sequence analysis for cloning was performed with
CLC Genomics Workbench 4.0. All restriction enzymes, DNA ligase, and
other molecular biology reagents were from New England BioLabs (NEB)
and used by following the provided instructions. PCR was performed with
Q5 high-fidelity DNA polymerase from NEB. The annealing temperature
was calculated based on the supplier’s information (Integrated DNA
Technologies). DNA was introduced into S. griseus ATCC 700974 by con-
jugation using E. coli ET12567/pUZ8002. Briefly, while E. coli in 10 ml of
LB was grown to an optical density at 600 nm (OD600) of0.4, 10l of S.
griseus spores in 0.5 ml of 2 yeast extract-tryptone (YT) medium was
subjected to heat shock for 10 min at 50°C and then allowed to cool to
room temperature. After a washing with fresh LB, 0.5-ml quantities each
of E. coli and Streptomyces were mixed, centrifuged at high speed, and
resuspended in 50 l of 2 YT. The resuspension was diluted with sterile
water from 101 to 104; 100 l of each dilution was plated onto an MS
plate. After 16 to 20 h, the plates were overlaid with 25 g/ml of nalidixic
acid and 12 g/ml of thiostrepton for replicating plasmids like pSE34 or
with 50g/ml of apramycin for integration mutants. After an additional 5
days, individual colonies were picked for bioassay and PCR verification.
Spores from at least three genetically confirmed transformants were
pooled to create a strain for biochemical analysis.
Construction of pCK for plasmid-based gene overexpression. The
pCK plasmids were constructed from pSE34-oriT, which has a mutated
ermE promoter (ermE*p) to drive the expression of genes cloned between
XbaI and HindIII. Because XbaI and NheI cuts generate compatible co-
hesive ends and a religated sequence will no longer be recognized by the
two enzymes, PCR fragments restricted with XbaI and NheI at the 5= and
3= ends, respectively, can be sequentially inserted into the XbaI site in the
pSE34-derived vector. Genes of interest were amplified using S. griseus
ATCC 700974 genomic DNA and a pair of primers, the names of which
indicate the target, direction, and a built-in restriction site for cloning
(Table 2). In some cases, the ribosomal binding site (RBS) of a target gene
was included within the 3= end of a fragment following the restriction site.
Control plasmid pA10 is the pSE34-oriT vector containing abmK (19).
The direct sulfhydrylation genes metYXSO were amplified as a single 4-kb
DNA fragment and cloned into pSE34-oriT to obtain pCK1. To assemble
the 2.4-kb malY-metB DNA fragment, PCR products were first assembled
in pDrive (Qiagen) and then moved into pSE34-oriT to yield pCK2. To
assemble the 2.6-kb mtcC-mtcB DNA fragment, PCR products were di-
rectly cloned into pSE34-oriT to yield pCK3. Cloning of the PCR-ampli-
fied 1.4-kb sahH and 2.3-kb metE DNA fragments into pSE34-oriT
yielded the pCK4 and pCK6 plasmids. The 1.2-kb metK DNA fragment
was first assembled with sahH as a two-gene operon in pDrive; then the
two-gene fragment was cloned into pSE34-oriT to obtain pCK5. A metE
fragment was also used to construct an3.9-kb XbaI-HindIII sahH-metE
DNA fragment, which was then cloned downstream of the XbaI-NheI
metK DNA fragment to obtain a 5.1-kb XbaI-HindIII metK-sahH-metE
TABLE 1 Bacterial strains and plasmids used or constructed in this study
Strain or plasmid Descriptiona Source or referenceb
Strains
E. coli
JM109 Strain used as a host for cloning and bioassay tester organism ATCC
ET12567 Strain harboring pUZ8002 plasmid; used for conjugating plasmid into Streptomyces 24
S. griseus
ATCC 700974 Wild type ATCC
SCAK1 WT-derived strain containing pSET and hrdBp-metYXSO at attB This study
SCAK2 WT-derived strain containing pSET and hrdBp-abmD at attB This study
SCAK3 WT-derived strain containing pSET and hrdBp-metYXSO-hrdBp-abmD-hrdBp-malY-metB at attB This study
SCAK4 WT-derived strain containing pSET and hrdBp-ask-asd at attB This study
SCAK5 WT-derived strain containing pSETand hrdBp-metYXSO-hrdBp-ask-asd at attB This study
S. albulus
NBRC 14147 Genome used to amplify the genes for feedback-insensitive Ask and Asd NBRC
Plasmids
pDrive Used for subcloning (Kanr Ampr) Qiagen
pSET(GUS) Used for subcloning (Aprr) 25
pSE34-oriT Multicopy plasmid in Streptomyces (Tsr) 19
pA10 pSE34 derivative control 19
pCK1 pSE34 derivative for ermE*p expression of metYXSO This study
pCK2 pSE34 derivative for ermE*p expression of malY-metB This study
pCK3 pSE34 derivative for ermE*p expression of mtcC-mtcB This study
pCK4 pSE34 derivative for ermE*p expression of sahH This study
pCK5 pSE34 derivative for ermE*p expression of metK-sahH This study
pCK6 pSE34 derivative for ermE*p expression of metE This study
pCK7 pSE34 derivative for ermE*p expression of metK-sahH-metE This study
a Tsr, thiostrepton resistant; ermE*p, mutated ermE promoter.
b ATCC, American Type Culture Collection; NBRC, Japanese NITE Biological Resource Center.
Improved Production of Albomycin by Streptomyces
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DNA fragment in pDrive. The three-gene assembly was cloned into
pSE34-oriT to obtain pCK7.
Construction of SCAK strains for integrative gene overexpression.
All pSCAK plasmids have a pSETGUS (25) vector backbone, and DNA
fragments were cloned using either BamHI or XbaI or both sites. The
hrdBp promoter was amplified from the genome in the form of an
0.3-kb EcoRI-XbaI DNA fragment to replace the ermE*p sequence in
the pCK plasmids mentioned above. Since the4.3-kb hrdBp-metYXSO
DNA fragment of the pCK1 derivative has a BamHI located in the inter-
genic region of metY-metX, a 1.4-kb XbaI-BglII DNA fragment from
hrdBp to the BamHI site was amplified using primers DirectS-F-XbaI and
DirectSinbet-R-BglII and used to replace the same-size XbaI-BamHI frag-
ment in the pCK1 derivative. The original BamHI was thus mutated due
to the religatable sticky ends from BamHI and BglII restriction. Using this
plasmid as a template and primers hrdBp-F-BamHI and DirectS-R-BglII,
the 4.3-kb BamHI-BglII DNA fragment was amplified and cloned into
pSET to obtain pSCAK1. Gene abmD was amplified as an 1-kb XbaI-
HindIII DNA fragment with primers abmD-F-XbaI and abmD-R-
HindIII and cloned into the hrdBp-containing pSE34 vector. Using this
plasmid as the template, a 1.3-kb BamHI-NheI hrdBp-abmD DNA frag-
ment was amplified with primers hrdBp-F-BamHI and abmD-R-NheI
and cloned into pSET to obtain pSCAK2. The pDrive vector was used to
first assemble a fragment with genes from multiple pathways. A 4.3-kb
BamHI-BglII hrdBp-metYXO fragment and a 1.3-kb EcoRI-HindIII
PhrdB-abmD fragment were amplified from pSCAK1 and pSCAK2, re-
spectively, using primer pairs hrdBp-F-BamHI/DirectS-R-BglII and
hrdBp-F-EcoRI/abmD-R-HindIII. A 2.7-kb HindIII-NheI hrdBp-malY-
metB DNA fragment was amplified from a pCK2 derivative. These frag-
ments were sequentially cloned into the pDrive vector to generate a six-
gene construct. The8.3-kb DNA insert was recovered as a BamHI-NheI
fragment and cloned into pSET to obtain pSCAK3. The ask-asd operon
has an internal BamHI site at position 416 of asd. Site-directed mutagen-
esis was performed to make a G416C mutation of the BamHI while
switching to a synonymous codon. It involved overlapping of two PCR
fragments, 1.68-kb and 0.753-kb DNA, amplified from the left and right
sides of the mutation site, using primers ask-asd-F-XbaI/asK-D-Rm and
asK-D-Fm/ask-asd-R-RBS-HindIII, respectively. The fragments were
then mixed and used as a template for another round of PCR using the two
inward primers. The amplified 2.4-kb XbaI-HindIII DNA fragment was
coligated with the 0.3-kb EcoRI-XbaI hrdBp DNA fragment into pSE34.
The resulting plasmid was used to amplify a 2.7-kb BamHI-NheI hrdBp-
ask-asd DNA fragment using primers hrdBp-F-BamHI and ask-asd-R-
RBS-NheI, which was then cloned into pSET to obtain pSCAK4. A 2.7-kb
HindIII-NheI hrdBp-ask-asdDNA fragment was amplified from pSCAK2
using hrdBp-F-HindIII and ask-asd-R-RBS-NheI. This fragment and the
4.3-kb BamHI-BglII hrdBp-metYXOS DNA fragment from pSCAK4 were
sequentially cloned into pDrive to generate a five-gene construct. The
BamHI-NheI 7.1-kb DNA insert was recovered from the pDrive plasmid
and cloned into pSET to obtain pSCAK5. The pSCAK plasmids were
introduced into S. griseus ATCC 700974 by conjugation. Chromosomally
integrated SCAK mutants, selected by apramycin resistance and verified
by PCR with purified genomic DNA, were confirmed to be stable through
several generations and minimally 7 months.
Growth of the wild type in PPGL-supplemented or iron-deficient
medium and CDW. S. griseus ATCC 700974 spores were grown in tryptic
soy broth (Bacto) for 2 days. Two milliliters of the seed culture was used to
inoculate 50 ml of APB in a 300-ml flask with extradeep baffles. The flasks
were shaken at 250 rpm and 28°C for 4 days and sampled at the desired
TABLE 2 DNA primers used for PCR in this study
Primer Sequence (5= to 3=) Purpose
DirectS-F-XbaI GAGGTCTAGAATGAGCCAGCCCCTCGACTCCGTCAC Cloning metYXSO into pSE34
DirectS-R-HindIII AAACCAAGCTTTTCGGTCCCGTCCCGGGTGCCGCC
CGL-F-XbaI AAAAAATCTAGATGAGCACCATGGGCGACGGAACACG Cloning mtcC into pSE34
CGL-R-RBS-NheI AAAAAAGCTAGCTCCTATCTACCGGACCGCCGCGTCCAGCGCCTG
CBS-F-XbaI AAAAAATCTAGAGTGCAATTCCACGATTCGATGATCAG Cloning mtcB into pSE34
CBS-R-HindIII AAAAAAAAGCTTTCAGGCCTTGGCCGTGCCCGCGTCCT
CBL-F-XbaI AAAAAATCTAGAGTGGGCGCGCCCTACGACTTCGATAC Cloning malY into pSE34
CBL-R-RBS-NheI AAAAAAGCTAGCTCCTATTCAATCGCCGGAGGGGCTTGTTCTCAG
CGS-F-XbaI AAAAAATCTAGAGTGGCCGGTAAGGGCCCTTGCGACG Cloning metB into pSE34
CGS-R-HindIII AAAAAAAAGCTTTCAGCCCAGCGCCTGGGTGAGGTCG
metK-F-XbaI AGGTCTAGAGTGTCCCGCCGCCTTTTCACCTCGG Cloning metK into pSE34
metK-R-HindIII CCTCCGAAGCTTTGTCCTGATGCTTGTACGGCCCTTACAGACC
metE-F-XbaI AAAAAATCTAGAGTGACAGCGAAGCCCGCAGCC Cloning metE into pSE34
metE-R-HindIII AAAAAAAAGCTTCGGATCACGCCGCTTCGGTGGGC
sahH-F-XbaI CAGTCTAGAATGACGACGACGACCAACCGT Cloning sahH into pSE34
sahH-R-RBS-NheI CTTCCGGCTAGCGGTCCTGGATCAGTAGCGGTAGTGGTC
hrdBp-F-BamHI AAAAAAGGATCCCATGCGTCACCTGCTCGTCGTCCATC Cloning hrdBp-linked constructs into pSET
hrdBp-F-EcoRI AAAAAAGAATTCCATGCGTCACCTGCTCGTCGTCCATC Cloning hrdBp promoter into pSE34
hrdBp-R-XbaI AAAAATCTAGAACCTCTCGGAACGATGGAAACGGC Cloning hrdBp promoter into pSE34
DirectSinbet-F-BamHI AAAAAAGGATCCGCCCGGTCGTCGCCGCTGGGC mutating the BamHI within metYXSO
DirectSinbet-R-BglII AAAAAAAGATCTCCCTCCCGTCGGCCACCGGAGGCCGGC mutation and for PCR verification
DirectS-R-BglII AAAAAAAGATCTTTCAGGTCACCGTCACCGGGTGCCGCAC Cloning metYXO into pSET
abmD-F-XbaI AAAAAATCTAGAATGACGGTCCTTCCCCT Cloning abmD into pSE34
abmD-R-HindIII AAAAAAAAGCTTGTCTCCTCTCGGGTAC Cloning abmD into pSE34
abmD-R-NheI AAAAAAGCTAGCGACGGGCGGTGGGC Cloning abmD into pSET
ask-asd-F-XbaI AAAAAATCTAGAGTGGGCCTTGTCGTGCAGAAGTACGGC Cloning ask-asd into pSE34
asK-D-Rm CCGCGCGGACGGATGCGCGCCGCGCACCCGTTGACCTC BamHI mutation primer
asK-D-Fm GCGCGGCGCGCATCCGTCCGCGCGGCATCATCGCCAAC BamHI mutation primer
ask-asd-R-RBS-HindIII AAAAAAAAGCTTTCCTATCCGGAGAATCAGCCGCCCCCTAAGAGC Cloning ask-asd from into pSE34
hrdBp-F-HindIII AAAAAAAAGCTTCCTCGTCGTCCATC Cloning hrdBp-ask-asd from pSCAK2 to pSET
ask-asd-R-RBS-NheI AAAAAAGCTAGCTCCTATCCGGAGAATCAGCCGCCCCCTAAGAGC
Kulkarni et al.
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time point. Propargylglycine (PPGL; Sigma) was added to a final concen-
tration of 9 mM at the time of inoculation. Iron-deficient medium was
prepared by excluding ferrous sulfate from the production medium. The
cell mass of the bacterial culture was measured by a modified method (26).
A bacterial culture (50 ml) was centrifuged to sediment the cells. The cell
pellets were resuspended in 3 ml of water, transferred onto a preweighed
glass dish, and then dried in a chamber at 80°C overnight. The weight
difference was reported as the cell dry weight (CDW).
Bioassay for determination of ABM production and titer. Agar dif-
fusion bioassay is a standard method for detecting microbial antagonism.
Since it was previously shown that ABM from S. griseus ATCC 700974 in
the defined medium APB is the sole agent responsible for the specific
bioactivity (19, 23), a bioassay was used to detect the production during
fermentation. An E. coli JM109 culture grown overnight was diluted to an
OD600 of0.1. A 100-l quantity of the diluted culture was pipetted onto
a Mueller-Hinton (MH) agar plate and spread evenly over the surface of
the agar with a sterile cotton swab. Wells were made in MH agar using the
back end of a 20- to 200-l tip, to which Streptomyces culture (20 l) was
added. The plate was incubated at 37°C, and a zone of inhibition which
formed in the E. coli lawn was read at 18 h. A bioassay plate was loaded
with serially diluted cultures or solutions for comparing and estimating
ABM concentrations (7, 23). A standard curve was generated with freshly
purified ABM, showing that the assay limit is about 2 ng in 20 l of
solution, which is 100 times more sensitive than high-performance liquid
chromatography (HPLC) quantitation. A linear regression between the
logarithm of the ABM concentration and the diameter of the zone was
identical to that reported previously (23) (see Fig. S1 in the supplemental
material).
HPLC-fluorescence detectionof intracellular thiol amino acids.The
major intracellular thiols were extracted by a modification of a previously
reported method (27). Cells from a 1-ml culture were pelleted by centrif-
ugation and then quickly washed twice with 1 ml of 2.63% NaCl solution.
HPLC-grade methanol prechilled at 20°C (1 ml of 60% solution) was
added to the tube. The pellet was resuspended, frozen in liquid nitrogen,
and stored at 80°C until extraction. A 20-l quantity of 2 mM mono-
bromobimane (Life Technologies), dissolved in acetonitrile (ACN), was
added to the suspension after thawing of the cells. The mixture was vor-
texed for 1 min and then immediately frozen in liquid nitrogen for 5 min.
This sequence of steps was repeated three times. The tube was centrifuged
at 5,000  g for 10 min at 4°C, and the supernatant was transferred to a
new tube and mixed with an equivalent amount of chloroform. After
centrifugation for 10 min at 13,000 g, the aqueous phase was recovered
and 10 l was analyzed by HPLC. As a negative control, 20 l of 2 mM
N-ethylmaleimide (NEM) in ethanol was added to the tube during cell
lysis. The data were collected with cultures grown for 4 days. HPLC was
performed using a Shimadzu Prominence system that included a photo-
diode array detector (SPD-M20A) and a fluorescence detector (RF-20A).
The HPLC system was equipped with an Alltech ALLSPHERE ODS-2 5
250- by 4.6-mm column, and the flow rate was maintained at 1.5 ml/min.
The gradient program from solvent A (H2O) to solvent B (ACN) was 0 to
40% B in 10 min, 40% to 80% solvent B in 5 min, 80% to 100% solvent B
in 2 min, 100% to 0% solvent A in 2 min, and 0% solvent A for 4 min.
ABM isolation and HPLC analysis of ABM production. The proce-
dures were modified from previous methods (19, 23). Cleared culture (50
ml) was mixed with 5 to 10 g of XAD-4 resin (Sigma). The resin was first
washed with 100 ml of water and then washed with 100 ml of 15% meth-
anol. ABM was eluted with 100 ml of 50% methanol, and the methanol
was removed with a rotary evaporator. The extract was lyophilized to
dryness and reconstituted in 1 ml of water. The extract (100 l) was used
for HPLC analysis in two steps. The first HPLC separation used a Phe-
nomenex Sphereclone C18 ODS-2 10 column (250 by 4.6 mm) with a
flow rate of 1.5 ml/min. The gradient program from solvent A (H2O in
0.01% formic acid) to solvent B (ACN in 0.01% formic acid) was 0 to 40%
solvent B in 15 min, 40% to 95% solvent B in 2 min, 95% solvent B for 3
min, 95% to 0% solvent B in 2 min, and 0% solvent B for 3 min. A
Shimadzu FRC-10A fraction collector was used to collect 0.5-ml fractions,
of which 20l was used in each bioassay. The active fractions (9.3 min)
were combined, lyophilized, and reconstituted in 100 l of water. ABM
was further purified using HPLC with a Phenomenex Kinetex XB-C-18
2.6 column (75 by 4.6 mm). The solvents were the same as described
above, and the flow rate was maintained at 1 ml/min. The gradient was
from 0 to 40% solvent B in 15 min, 40% to 95% solvent B in 2 min, 95%
solvent B for 3 min, 95% to 0% solvent B in 3 min, and 0% solvent B for 7
min. ABM was eluted at 6.5 min and verified by high-resolution mass
spectrometry, UV-visible (UV-VIS) absorption spectrum, and the corre-
sponding bioactivity. A standard curve of HPLC peak area versus the
amount of pure ABM analyzed was prepared (see Fig. S2 in the supple-
mental material).
RESULTS AND DISCUSSION
Intracellular flux of free-thiol amino acids in relation to ABM
production. Gene abmD was predicted to encode a pyridoxal
phosphate (PLP)-dependent enzyme that is similar to ACCD (1-
aminocyclopropane-1-carboxylic acid) deaminase (E value,
2e55) (19) through sequence alignment or cystathionine--
synthase (CBS; E value, 4e67) through structural predictions. It
also has weak homology to D-cysteine desulfhydrases. AbmD pro-
duced and purified from E. coli showed the expected absorbance
maximum at410 nm at pH 8.0 (see Fig. S3 in the supplemental
material), which is indicative of a PLP-containing enzyme. AbmD
is the only ABM biosynthetic enzyme that displayed absorption,
suggesting that AbmD catalyzes a reaction that can be a key link
between primary and secondary metabolism by utilizing one of
the two free-thiol amino acids to perform the first committed step
of the pathway. While functional investigation of AbmD is ongo-
ing, we tested whether ABM biosynthesis would be controlled by
the abmD gene product in a productive manner (28).
We examined the intracellular flux of Hcy and Cys in relation
to ABM production (Fig. 2). An HPLC-fluorescence method was
used to monitor the relative concentrations of Hcy and Cys since
the two metabolites were the only major free-thiol amino acids
detected in the cells under various fermentation conditions. It was
previously reported that iron (Fe2 or Fe3) supplementation in
the growth medium (up to 1 mM) significantly increased ABM
production, and this increase was positively correlated (23). We
therefore asked whether iron would also affect intracellular levels
of Hcy and Cys. When wild-type (WT) S. griseus was grown in
glycerol-based ABM production broth without iron supplemen-
tation (APBiron), the residual iron in other medium compo-
nents was sufficient to support growth to 70% of the cell dry
weight (CDW) of cultures from normal APB (2.75 g versus 3.92	
0.08 g/liter), but very little ABM production was observed after a
4-day incubation (Fig. 2A). Intracellular Hcy was barely detected
in the iron-deficient cells (Fig. 2B, HPLC trace iv), while the
amount of Hcy was significantly greater in iron-supplemented
cells (Fig. 2B, HPLC trace v). Hcy in the APB sample was three
times that in the APB-iron sample when it was normalized to the
Cys detected with the same method. We next examined the effect
of supplementing the culture with propargylglycine (PPGL),
which is known to inhibit SAA metabolism in vivo. PPGL func-
tions as a mechanism-based inhibitor of the transsulfuration re-
actions, targeting both CGS and CGL proteins (Fig. 1) (29, 30),
but it is less effective on direct sulfhydrylation (31). PPGL was
previously shown to inhibit the synthesis of a cysteine-containing
antibiotic, thienamycin, produced by Streptomyces cattleya NRRL
8057 (30). The WT S. griseus strain was grown in APB in the
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presence of PPGL (APBPPGL). While the cells grew to a CDW
(3.20	 0.17 g/liter) that was81% of normal growth, the PPGL-
treated culture produced 30 to 50% more ABM on day 4, as de-
termined by both bioassay and HPLC quantification of the puri-
fied ABM (Fig. 2C; see also Fig. S4 in the supplemental material).
Thus, unlike thienamycin production, albomycin production
does not seem to depend upon the transsulfuration pathways.
Furthermore, in the profile of SAA, both Cys and Hcy peaks de-
creased but the relative amount of Hcy increased to 19.7% (Fig.
2B, HPLC traces v and vi). Taking into consideration the three
independent growth conditions, the results suggest that an in-
crease in ABM production is correlated with an increase in the
relative intracellular concentration of Hcy.
Key SAAmetabolic genes in S. griseus and functional assign-
ment. We previously reported that the genome of the ABM pro-
ducer is very similar to that of the well-studied S. griseus NBRC
13350 (19). A preliminary genome-scale comparison is presented
in Fig. S5 in the supplemental material. Since there are few reports
concerning SAA metabolic genes in Streptomyces (32), we used the
RAST genome annotation server (33) to identify candidates in the
whole genome of NBRC 13350 (34). Ten major SAA metabolic
genes or open reading frames (ORFs) were identified (Fig. 1),
suggesting that S. griseus is Cys and Met prototrophic. Their ho-
mologs were subsequently identified in the S. griseus ATCC
700974 genome. Nucleotide identity between the genes of NBRC
13350 and ATCC 700974 (see Table S1 in the supplemental mate-
rial) is 93.7% on average, with the highest at 97% (sahH) and the
lowest at 89% (malY). The two closely related S. griseus strains can
be used to perform genomic research of Streptomyces, such as on
housekeeping genes and the conserved functions (35), as well as
small noncoding RNAs (36).
Several subclasses of PLP-dependent enzymes are involved in
the formation of thiol amino acids (14, 37), and the functions of
the assigned ORFs were interrogated. The amplified ORFs of each
pathway were assembled into a cassette for expression under the
control of the ermE*p promoter in Streptomyces multicopy plas-
mid pSE34-oriT (19). It should be noted that direct sulfhydryla-
tion ORFs sgr6647 and sgr6646 (metY and -X) appear in both
genomes and are located in a genetic operon with a third ORF,
sgr6645 (metSO), encoding a putative sulfite oxidase, immediately
downstream of sgr6646. The three ORFs were amplified and
cloned as one DNA fragment for expression. The different plas-
mids were separately introduced into S. griseus, and the fermen-
tation cultures of the positive transformants were analyzed for
ABM production and Hcy/Cys levels. Overexpression of the direct
sulfhydrylation ORFs in pCK1 and transsulfuration ORFs sgr3417
and sgr2579 (malY and metB) in pCK2 caused an increase of Hcy
relative to Cys, while the reverse transsulfuration ORFs sgr3660
and sgr4452 (mtcC and mtcB) in pCK3 caused a reduction of in-
tracellular Hcy, although the effect was less pronounced (Fig. 3A
and B). These results are consistent with expectations for SAA
metabolism. Overexpression of metYXSO increased overall intra-
FIG 2 Relationship of ABM production and intracellular free-thiol amino acids of WT S. griseus. (A) Bioassay with cells grown in the absence (APB-iron)
or presence (APB) of 1 mM iron in a glycerol-based ABM production medium (APB). The size of the inhibition zone is proportional to the amount of ABM in
the culture assayed (see Materials and Methods). (B) HPLC-fluorescence detection of monobromobimane-derived intracellular amino acids. Cysteine (●) and
homocysteine () are the only two free-thiol amino acids detected under these conditions. The chromatograms show (i) and (ii) standards, (iii) N-ethylma-
leimide (NEM)-treated intracellular metabolic extracts (the negative control), (iv) cells in APB without iron, (v) cells in normal APB with 1 mM iron, and (vi)
cells in APB supplemented with 9 mM propargylglycine (APBPPGL). Percentage ratios of the peak areas of the two thiols are shown for traces iv, v, and vi. The
standard error of three replicates for each was0.2. (C) ABM production of cells grown in APB or APBPPGL. ABM was quantified by isolation and HPLC
analysis. The statistical significance was derived from nine experimental replicates; the standard error is presented by an error bar. **, P
 0.01 (t test).
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cellular thiol amino acid concentrations, and this increase was
significantly greater than for recombinant strains expressing
malY-metB (Fig. 3A). The recombinant strains also produced
ABM at different levels (Fig. 3C). The additional metYXSO in
pCK1 enabled the highest ABM production compared to the con-
trol plasmid without the genes, while the addition of mtcC-mtcB
(pCK3) led to comparable levels of ABM production relative to
the control. No difference in the CDWs of these strains was ob-
served. The results agreed in general with the functional assign-
ment of the SAA metabolic genes. Moreover, the results revealed
that a higher level of Hcy caused by the gene expression is not toxic
to S. griseus and, importantly, that increased Hcy improves ABM
production. The overflow of Hcy could be redirected to the ABM
pathway by overexpressing the gate-keeping enzyme AbmD. A
comparable engineering strategy leading to improved production
of microbial metabolites has been reported for other systems,
such as cephamycin C-producing Streptomyces (28).
Overexpression of Hcy synthesis genes and abmD for im-
proved and stable ABM production. Hcy concentration can be
increased by inserting genetic constructs directly into the chromo-
some. The S. griseus draft genome was searched for two genetic
elements for chromosomal incorporation of exogenous DNA.
The first element was a phageC31 attB site that allows the inte-
gration of pSET vector-carried DNA into a host chromosome
(38). A 51-bp sequence in a hypothetical protein gene (39), highly
similar to the attB sequences found in other Streptomyces ge-
nomes, was identified (Fig. 4A). The second genetic element is a
constitutive promoter, such as hrdBp, often used in Streptomyces
genetic engineering (26). HrdB is a principal sigma factor that has
been studied in S. griseus (40). The genes encoding HrdB (sgr1701)
in the two S. griseus strains are 96% identical. The promoter hrdBp
was defined as an350-bp DNA upstream sequence. We initially
constructed a chromosomally integrated mutant, SCAK1, that has
the direct sulfhydrylation genesmetYXSO under the control of the
hrdBp promoter sequence (Fig. 4B; see also Fig. S6 in the supple-
mental material). As expected, the intracellular concentration of
Hcy of SCAK1 increased to a level almost equal to that of Cys (see
Fig. S7 in the supplemental material). While ABM production by
SCAK1 increased (Fig. 4C and D), the CDW of SCAK1 at day 4
decreased to 2.22	 0.27 g/liter, compared to the CDW of the WT,
3.92 	 0.08 g/liter. We also made an abmD-integrated mutant,
SCAK2 (Fig. 4B), that has abmD under the control of the hrdBp
promoter, and the exconjugants (attB::pSCAK2) were obtained at
a much lower frequency than for SCAK1 generation and the dou-
ble-crossover mutant previously prepared (19). After several tri-
als, we managed to isolate one such mutant, SCAK2 (see Fig. S6 in
the supplemental material), from the 102 to 103 dilution of a
conjugation mixture. ABM production by SCAK2 was nearly dou-
ble that of the wild-type strain (Fig. 4C and D).
To demonstrate that ABM production is jointly controlled by
Hcy flux and abmD expression, the transsulfuration genes (malY-
metB) under the control of hrdBp were included with abmD and
the direct sulhydrylation genes (metXYSO) to generate the inte-
grated mutant strain SCAK3 (Fig. 4B). The transformed colonies
FIG 3 Effect of plasmid-based overexpression of the identified sulfur amino acid metabolic genes in WT S. griseus. (A) HPLC-fluorescence chromatograms of
intracellular Cys and Hcy detected in the transformed strains. (B) Relative percentages of intracellular Cys and Hcy. For each strain that is a mixture of 3 to 5
individual colonies, the percentage is an average of three independent measures. (C) ABM production level. The introduced plasmids are described in Table 1.
Each production level is the average of at least three experimental replicates; the standard error is represented by an error bar. Statistical significance was
determined by comparing the level of a specific strain to the control. **, P
 0.01; NS, not significant.
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were readily prepared and verified by PCR (see Fig. S6 in the sup-
plemental material). Thirty colonies were screened using the an-
tibacterial bioassay, and 27 colonies gave a larger zone of inhi-
bition than that of the WT strain. These colonies all produced
similarly high levels of ABM. Several colonies were pooled to cre-
ate strain SCAK3 for the subsequent metabolic analyses. The Hcy
level in the SCAK3 cells was steadily low, and the CDW of SCAK3
was reproducibly 4.25	 0.24 g/liter, comparable to or better than
that of the WT, suggesting that the growth problem of the two
early mutants can be overcome by a combined action of the pre-
cursor supply pathways and overexpression of rate-limiting
abmD. ABM production by SCAK3 was 400% that for the WT
strain and200% that for the SCAK1 or SCAK2 strain (Fig. 4C),
indicating that the co-overexpression of abmD has efficiently di-
verted the augmented Hcy flux into ABM biosynthesis. Further-
more, no antibiotics were needed to maintain the ABM overpro-
duction phenotype, although the SCAK3 strain was repeatedly
passed through medium without selection. Thus, a stable, high-
level ABM producer was generated. Although it is known that
some bacteria cannot tolerate an elevation of intracellular Hcy
(41), this strategy has the potential to be used to discover ABM-
like molecules potentially produced by other actinomycetes, such
as Streptomyces C (19).
Exploring metabolic switches and sulfur source for increas-
ing ABM production. Biosynthesis of methionine in bacteria is
linked to central carbon metabolism and whole-cell physiology via
additional metabolic pathways: one is the aspartate-to-homoser-
ine path of C4 metabolism that starts with aspartokinase (Ask) and
aspartate semialdehyde dehydrogenase (Asd), and another is the
activated methyl cycle (AMC) of C1 metabolism (Fig. 1). The C4
carbon flow is controlled by a feedback inhibition mechanism of
Ask and Asd. Streptomyces albulus NBRC 14147 encodes an inhi-
bition-resistant Ask in the ask-asd operon, which is a major reason
that it produces an aspartate-derived antibiotic product at a gram/
liter level (42). AMC has two metabolic controlling elements as
well. First, S-adenosyl-L-methionine (SAM)-dependent methyl-
transferases are subject to S-adenosyl-L-homocysteine (SAH)
product inhibition. Without sufficient SAH hydrolase to degrade
the coproduct generated by SAM-dependent enzymes, including
AbmI (19), a cell’s primary metabolism is impeded. Second, SAM
is shared by many biological pathways, and the supply is limited.
Thus, an exogenous supply of SAM or overexpression of SAM
synthetase (MetK) has been reported to increase the production of
antibiotics in Streptomyces (43). We attempted to explore these
master metabolic switches for increasing ABM production by ge-
netic manipulation. Single- or multiple-gene constructs were
FIG 4 Chromosomal integration of genetic constructs for increasing sulfur-carbon flow toward Hcy and the improved ABM production. (A) Comparison of
attB sequences identified in the Streptomyces genomes. (B) Diagram of the major chromosomally integrated constructs. (C) HPLC chromatograms of purified
albomycins of S. griseus ATCC 900794 WT and the mutants. Albomycin 2 is the major product. Other albomycin congener (ferrichrome) or variants (1) were
eluted from the HPLC column before or after the 2. (D) ABM production of the analyzed chromosomal mutants. Each production level is the average of at least
three experimental replicates; the standard error is represented by an error bar. **, P
 0.01.
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cloned into pSE34-oriT under the control of ermE*p for expres-
sion in WT S. griseus. As shown in Fig. 5, sahHoverexpression with
pCK4 improved ABM production, but the effect was less than with
metK-sahH coexpression with pCK5. Overexpression of metE
with pCK6 did not cause a change of ABM production, while the
coexpression of the three genes with pCK7 only slightly increased
ABM production levels (Fig. 5). The overexpression of metE was
unable to compete with natural abmD but reduced the positive
effect ofmetK-sahH coexpression. CDWs of strains carrying pCK4
and pCK5 were15% more than for the control strain, indicating
the important role of metK and sahH in cell fitness rather than
having a specific effect on ABM biosynthesis. We finally made two
more chromosomally integrated mutants, SCAK4 (hrdBp-ask-
asd) and SCAK5 (hrdBp-metYXSO-hrdBp-ask-asd). Both of them
showed a modest but reproducible increase of ABM production
(Fig. 5). We have yet to confirm whether Ask/Asd enzyme activi-
ties are elevated in SCAK4 and SCAK5. However, in glycerol-
based medium, the levels of intracellular Cys and Hcy were nearly
identical, suggesting that the increased Hcy flux caused by the
ask-asd played a direct role in the increase in ABM production.
Future engineering efforts involving C1 and C4 metabolism for
optimizing ABM production will likely need to consider the major
carbon source of fermentation.
In addition to engineering the metabolic switches related to
SAA metabolism, we also thought that a more reduced sulfur
source in the medium might increase ABM production. So-
dium sulfide cannot be used because it reacts immediately with
iron to form a precipitate; thus, thiosulfate supplementation
was examined. SCAK3 grew normally in thiosulfate-based me-
dium, but ABM production was not increased. It remains un-
known whether S. griseus has a thiosulfate reductase activity.
Overall, the results are consistent with the higher-order metabolic
regulatory circuits such as AMC, Ask/Asd, and sulfur assimilation
in S. griseus having an indirect role in ABM production by altering
Hcy flux.
SCAK3’s growth and ABM production level in an optimized
medium. It was reported that WT S. griseus produced ABM at 1 to
2 mg/liter during standard fermentation (23). In addition to iron
and buffering agents, ornithine and specific carbon sources in
the medium were shown to be important for high-level ABM
production by selected clones. Nonetheless, high-level-pro-
ducing strains could not be preserved for a long period. At the
outset of our experiments that lasted 8 months, the strains
were grown up in glycerol-APB medium without ornithine,
and ABM was isolated and quantified with HPLC. The yield was
0.20 	 0.013 mg/liter or 0.85 	 0.046 mg/liter for WT or
SCAK3, respectively, when fermented in flasks with rigorous
shaking. Adding ornithine alone to the glycerol-APB medium
did not improve ABM production in SCAK3. The previously
optimized medium, which contains ornithine and 2% starch,
supported a higher ABM production by SCAK3 with the shake
flask method; however, the ABM purification process became
significantly more complex under those conditions. We then
used the bioassay to determine the ABM titer and estimated the
production by SCAK3 in the optimized medium despite this
problem (Fig. 6A). ABM production peaked at day 4, when the
level for SCAK3 (11 mg/liter) was three times as much as for
the WT (3.7 mg/liter) (Fig. 6B). The CDWs of both cultures
reached the highest level at day 3 (Fig. 6C), when SCAK3’s mass
was about twice that of the WT in flasks. Starting at day 4, the
CDW of SCAK3 decreased toward the end, while the CDW of
the WT changed less even after ABM production ceased. This
observation indicated that more SCAK3 cells might have lysed
once it produced a large amount of ABM in the shake flask
fermentation. Nonetheless, the SCAK3 strain produced more
ABM than the WT strain in the optimized medium at a given
time. Since ABM production by the WT could be increased up
to 25 mg/liter in a fed-batch fermentor (23), we estimate that
ABM production by SCAK3 will approach 100 mg/liter. The
purification of highly water-soluble small-peptide ABM and
ABM derivatives remains challenging but solvable. A more ef-
ficient ABM purification process will be needed to improve the
yields for further preclinical studies or for generating ABM
analogs by mutasynthesis or semisynthesis.
In summary, ABM is an antibacterial agent that was chosen for
pharmaceutical development long before the genomic era (6, 12,
13, 44). A rational metabolic engineering strategy for increasing
ABM production was adopted in this study. We analyzed two
free-thiol amino acids, Cys and Hcy, in the model producing
strain, S. griseus ATCC 700974, and correlated the levels to ABM
production. We showed that the intracellular concentration of
Hcy relative to that of Cys could be dramatically increased by
overexpression of genes involved in direct sulfhydrylation and
transsulfuration pathways. Refactoring of the primary meta-
bolic genes for constitutive expression and integration into the
chromosome, along with providing a duplicate abmD gene for
the proposed initial step of the biosynthesis of the nucleoside
component of ABM, resulted in a genetically stable, high-level
ABM producer. In a glycerol-based medium, the ABM produc-
tion level of the resulting strain, SCAK3, quantified by isolation
and HPLC, was three times more than that of the WT. Thus,
although ABM biosynthesis in this strain is apparently not con-
trolled by a pathway-specific regulatory gene, ABM production
can be manipulated by genetic engineering of the Hcy branch
point of SAA metabolism in Streptomyces. The present research
has only focused on limited principles of metabolic engineer-
ing for increasing ABM production. Further improvement is
expected upon a more thorough metabolomic analysis of S.
griseus as well as whole-cell modeling of the production event.
At the enzyme level, AbmD is proposed to catalyze S-C bond
formation using two building blocks, a hydroxyl-activated ser-
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ine and an Hcy (see Fig. S8 in the supplemental material). The
reaction path should be interesting due to its deviation from
the course of plant ACCD (45) or human CBS (46), offering yet
another microbial example of the diversity of the PLP-depen-
dent enzyme superfamily.
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